Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Marek Kaszuba, Agnieszka Śliwka, Rafał Piliński, Jolanta Kościelniak, Paweł Maga, Grażyna Bochenek & Roman Nowobilski. (2019) The Comorbidity of Chronic Obstructive Pulmonary Disease and Peripheral Artery Disease – A Systematic Review. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:3-4, pages 292-302.
Read now
Read now
Kuang-Ming Liao, Lu-Ting Kuo & Hsueh-Yi Lu. (2019) Increased risk of peripheral arterial occlusive diseases in patients with chronic obstructive pulmonary disease: a nationwide study in Taiwan. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1455-1464.
Read now
Read now
I. Tuleta, N. Eckstein, F. Aurich, G. Nickenig, C. Schaefer, D. Skowasch & R. Schueler. (2019) Reduced longitudinal cardiac strain in asthma patients. Journal of Asthma 56:4, pages 350-359.
Read now
Read now
Articles from other publishers (10)
Stanislav Kotlyarov & Anna Kotlyarova. (2022) Molecular Pharmacology of Inflammation Resolution in Atherosclerosis. International Journal of Molecular Sciences 23:9, pages 4808.
Crossref
Crossref
Stanislav Kotlyarov. (2022) Analysis of differentially expressed genes and signaling pathways involved in atherosclerosis and chronic obstructive pulmonary disease. Biomolecular Concepts 13:1, pages 34-54.
Crossref
Crossref
Stanislav Kotlyarov & Anna Kotlyarova. (2021) The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis. International Journal of Molecular Sciences 22:13, pages 6711.
Crossref
Crossref
Fatemeh Zeynab Kiani & Ali Ahmadi. (2021) Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN cohort study in southwest Iran. Scientific Reports 11:1.
Crossref
Crossref
I. O. KhramtsovaM. A. DerbakT. M. GanichV. V. SvistakO. T. Ganich. (2021) FREQUENCY OF THE LIVER INJURY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ACCORDING TO THE RESULTS OF NON-INVASIVE METHODS OF RESEARCH. Bulletin of Problems Biology and Medicine 3:1, pages 153.
Crossref
Crossref
E. B. Klester, Ya. N. Shoykhet, A. S. Balitskaya, K. N. Zhuravlev, V. A. Elykomov, I. V. Bakhareva, A. V. Bocharova, V. G. Yarkova & K. V. Klester. (2020) Pulmonary hemodynamics and remodeling of the right heart in patients with COPD depending on the risk group, the direction of drug correction. PULMONOLOGIYA 30:6, pages 756-763.
Crossref
Crossref
Ana Constantin & Florin Mihălțan. (2020) Comorbidities, COPD and COVID 19. Pneumologia 69:2, pages 69-72.
Crossref
Crossref
Michael J. Hughes, Helen M. McGettrick & Elizabeth Sapey. (2020) Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target. European Respiratory Review 29:155, pages 190102.
Crossref
Crossref
Yen-Jung ChenYun-Chung LiuYu-Wen LiuYu-Bin LeeHsin-Chieh HuangYi-Yun ChenYao-Hsiang ShihYing-Chu LeeChing-Feng ChengTzu-Ching Meng. (2019)
Nitrite Protects Neurons Against Hypoxic Damage Through
S
-nitrosylation of Caspase-6
. Antioxidants & Redox Signaling 31:2, pages 109-126.
Crossref
Crossref
Renáta M. Böcskei, Béla Benczúr, György Losonczy, Miklós Illyés, Attila Cziráki, Veronika Müller, Anikó Bohács & András Bikov. (2019) Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD. Lung 197:2, pages 189-197.
Crossref
Crossref